Statin Therapy in Elderly Patients

Indications and Intensity

The American College of Cardiology recommends starting high-intensity statin therapy immediately in patients with established ASCVD, regardless of age or baseline LDL cholesterol level 1, 2, 3.
For patients with diabetes without ASCVD, the American Diabetes Association recommends starting at least moderate-intensity statin therapy, with a goal of reducing LDL cholesterol by 30-49% 7, 8.
The American College of Cardiology recommends starting high-intensity statin therapy in patients with primary hyperlipidemia (LDL ≥190 mg/dL), with a goal of reducing LDL cholesterol by at least 50% 2, 3.
For patients with multiple risk factors without ASCVD or diabetes, the American College of Cardiology recommends starting moderate-intensity statin therapy, with a goal of reducing LDL cholesterol by 30-49% 1, 3.

The American College of Cardiology recommends assessing LDL cholesterol 4-12 weeks after initiation of statin therapy to evaluate response and adherence 1, 2, 3.
The American College of Cardiology recommends obtaining annual lipid profiles once stable on therapy 3, 8.

The American College of Cardiology states that age should not be a barrier to statin therapy, as the relative risk reduction is similar across age groups, and absolute benefit may actually be greater in elderly patients due to higher baseline cardiovascular risk 4, 5, 6.
The American College of Cardiology recommends considering functional status and life expectancy when deciding whether to initiate or continue statin therapy in elderly patients 1, 4, 5.
The American College of Cardiology states that clinical judgment is required beyond Framingham risk scoring for older persons at high risk without established CVD, taking into account factors such as efficacy, safety, and patient preference 4, 5, 6.